|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM278501141 |
003 |
DE-627 |
005 |
20231225020731.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2017 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.15844/pedneurbriefs-31-3-3
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0928.xml
|
035 |
|
|
|a (DE-627)NLM278501141
|
035 |
|
|
|a (NLM)29184381
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Mithal, Divakar S
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Anticonvulsant Medications in Mitochondrial Disease
|
264 |
|
1 |
|c 2017
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Revised 01.10.2020
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a CommentOn: Epilepsy Res. 2017 Oct;136:5-11. - PMID 28732239
|
500 |
|
|
|a Citation Status PubMed-not-MEDLINE
|
520 |
|
|
|a Researchers from Vienna, Austria and Sao Paulo, Brazil studied the known effects of anticonvulsant drugs on mitochondria, using a literature search to include only references to epilepsy associated with mitochondrial disease, and a specific anti-convulsant drug (i.e. levetiracetam) with a specific mitochondrial function (i.e. mitochondrial membrane potential)
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Comment
|
650 |
|
4 |
|a Anti-Convulsant
|
650 |
|
4 |
|a Anti-Epileptic Drug
|
650 |
|
4 |
|a Epilepsy
|
650 |
|
4 |
|a Mitochondrial Disease
|
700 |
1 |
|
|a Kurz, Jonathan E
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Pediatric neurology briefs
|d 1997
|g 31(2017), 3 vom: 09. Nov., Seite 9
|w (DE-627)NLM098248251
|x 1043-3155
|7 nnns
|
773 |
1 |
8 |
|g volume:31
|g year:2017
|g number:3
|g day:09
|g month:11
|g pages:9
|
856 |
4 |
0 |
|u http://dx.doi.org/10.15844/pedneurbriefs-31-3-3
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 31
|j 2017
|e 3
|b 09
|c 11
|h 9
|